Engineering Graphene for developing Neural Interfaces to revolutionize how we tr...
Engineering Graphene for developing Neural Interfaces to revolutionize how we treat neurological diseases
Neurological disorders represent one of the greatest healthcare challenges for our society (1B affected people worldwide). 25-35% of these patients are refractory to pharmacological therapy and are left with no options. Neuroelect...
ver más
INBRAIN NEUROELECTRONICS
Ofrecer productos, componentes, dispositivos, metodos y servicios de consultoria, investigacion y desarrollo relacionados con la salud cereb...
TRL
6-7
| 207K€
Fecha límite participación
Sin fecha límite de participación.
Financiación
concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto
el día 2023-04-06
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Información proyecto EGNITE
Duración del proyecto: 24 meses
Fecha Inicio: 2023-04-06
Fecha Fin: 2025-04-30
Líder del proyecto
INBRAIN NEUROELECTRONICS
Ofrecer productos, componentes, dispositivos, metodos y servicios de consultoria, investigacion y desarrollo relacionados con la salud cereb...
TRL
6-7
| 207K€
Presupuesto del proyecto
4M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Neurological disorders represent one of the greatest healthcare challenges for our society (1B affected people worldwide). 25-35% of these patients are refractory to pharmacological therapy and are left with no options. Neuroelectronic therapies, aimed at recording and stimulating brain activity to restore normal brain function, are emerging as a safe alternative for them. However, current neuroelectronic implants are made of big metal leads with multiple limitations, such as poor resolution, low specificity and high invasiveness.
We, at INBRAIN Neuroelectronics, have the solution. We are developing a completed platform of intelligent neuroelectronic interface systems powered by Graphene dots. We are developing graphene-based neural implants that, powered by AI, will have the capability of reading single neural cells at a resolution never seen before, detecting therapy-specific biomarkers and triggering adaptive responses for increased outcomes in personalized neurological therapies.